Cancer Dx Firm On-Q-ity Debuts with $21M Series A Financing Round | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics startup On-Q-ity said today that it has closed a $21 million Series A financing round to support the development of a biomarker-based diagnostic for predicting and monitoring cancer treatment effectiveness.

MDV-Mohr Davidow Ventures led the financing round, which also included Bessemer Venture Partners, Physic Ventures, and Northgate Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."